First report of tumor treating fields (TTFields) therapy for glioblastoma in comorbidity with multiple sclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Brain sciences ; 12 (2022), 4. - eISSN 2076-3425
- Keyword
-
Glioblastom
Multiple Sklerose
Tumortherapiefelder
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2022
- Creator
-
Kassubek, Rebecca
Mathieu, René
- DOI
-
10.18725/OPARU-51730
- URN
-
urn:nbn:de:bsz:289-oparu-51806-0
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:44 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kassubek, Rebecca
- Mathieu, René
- Universität Ulm
Time of origin
- 2022
Other Objects (12)
Treating systematic errors in multiple sclerosis data
Targeted therapy to overcome the blood-brain barrier in treating Glioblastoma
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
Apheresis therapy in immunopathologically classified multiple sclerosis patients
Predictors for therapy response to intrathecal corticosteroid therapy in Multiple Sclerosis
Multiple sclerosis
Multiple sclerosis
Autoantibodies in multiple sclerosis
Primary progressive multiple sclerosis
Multiple Sclerosis and Schizophrenia
Neurodegeneration in multiple sclerosis
Cognition in multiple sclerosis
Treating systematic errors in multiple sclerosis data
Targeted therapy to overcome the blood-brain barrier in treating Glioblastoma
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
Apheresis therapy in immunopathologically classified multiple sclerosis patients
Predictors for therapy response to intrathecal corticosteroid therapy in Multiple Sclerosis
Multiple sclerosis
Multiple sclerosis
Autoantibodies in multiple sclerosis
Primary progressive multiple sclerosis
Multiple Sclerosis and Schizophrenia
Neurodegeneration in multiple sclerosis
Cognition in multiple sclerosis
Treating systematic errors in multiple sclerosis data
Targeted therapy to overcome the blood-brain barrier in treating Glioblastoma
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
Apheresis therapy in immunopathologically classified multiple sclerosis patients
Predictors for therapy response to intrathecal corticosteroid therapy in Multiple Sclerosis
Multiple sclerosis
Multiple sclerosis
Autoantibodies in multiple sclerosis
Primary progressive multiple sclerosis
Multiple Sclerosis and Schizophrenia
Neurodegeneration in multiple sclerosis